✦ LIBER ✦

A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia

✍ Scribed by Lesley M Arnold; Evelyn V Hess; James I Hudson; Jeffrey A Welge; Sarah E Berno; Paul E Keck Jr

Book ID: 117013727
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 93 KB
Volume: 112
Category: Article
ISSN: 1555-7162
DOI: 10.1016/s0002-9343(01)01089-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Flexible dosed duloxetine versus placebo

Flexible dosed duloxetine versus placebo in the treatment of fibromyalgia: a randomized, double-blind trial

✍ D. Clauw; L. Arnold; F. Wang; J. Ahl; P. Gaynor; M. Wohlreich 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Citalopram in patients with fibromyalgia

Citalopram in patients with fibromyalgia— a randomized, double-blind, placebo-controlled study

✍ Ulla Maria Anderberg; Ina Marteinsdottir; Lars von Knorring 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 121 KB

A Randomized, Double-Blind, Placebo-cont

A Randomized, Double-Blind, Placebo-controlled Study of Growth Hormone in the Treatment of Fibromyalgia

✍ Robert M Bennett MD; Sharon C Clark PhD; Jacqueline Walczyk MS 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Saffron for treatment of fluoxetine-indu

Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study

✍ Kashani, Ladan; Raisi, Firoozeh; Saroukhani, Sepideh; Sohrabi, Hamid; Modabberni 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Gabapentin in the treatment of fibromyal

Gabapentin in the treatment of fibromyalgia: A randomized, double-blind, placebo-controlled, multicenter trial

✍ Lesley M. Arnold; Don L. Goldenberg; Sharon B. Stanford; Justine K. Lalonde; H. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 3 views

## Abstract ## Objective To assess the efficacy and safety of gabapentin in patients with fibromyalgia. ## Methods A 12‐week, randomized, double‐blind study was designed to compare gabapentin (1,200–2,400 mg/day) (n = 75 patients) with placebo (n = 75 patients) for efficacy and safety in treatin

Escitalopram in the treatment of general

Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study

✍ Jonathan R.T. Davidson; Anjana Bose; Andrew Korotzer; Hongjie Zheng 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Escitalopram has been shown in clinical trials to improve anxiety symptoms associated with depression, panic disorder, and social anxiety disorder. This study was designed to evaluate the efficacy and tolerability of escitalopram in the treatment of generalized anxiety disorder (GAD). Outpatients (1